Unifying the Treatment Community

National Methadone Conference AMTA 2001

Sunday, October 7th


Pre-conference Meeting

This special pre-conference meeting is divided into two sessions – a morning and afternoon session. These sessions have been developed by the Advocacy Coalition: National Alliance of Methadone Advocates (NAMA), Advocates for Recovery through Medicine (ARM), Advocates For the Integration of Recovery and Methadone (AFIRM), Virginia Alliance of Methadone Advocates (VAMA), and Addiction Treatment Watchdog, and are designed to take the combined knowledge and experience of the advocacy community and present concepts that will assist in the understanding of medication assisted treatments like methadone and LAAM, as well as the new regulations (42 CRF Part 8) and accreditation, from both the patient’s and the staff’s perspective. Audiences for these sessions include patients, counselors, medical and administrative personnel, advocates and all others involved in the field of opioid agonist treatment.

8:30 A.M. to 12 Noon Session: Accreditation, Networking and Skill Building

Nuts and Bolts of Regulations/Accreditation
Presenter: C. Todd Rosendale, CSAT/OPAT

Group Discussion on Advocacy
Moderator: Joycelyn Woods, NAMA

Networking & How Best to Utilize Time and Skills at a Conference
Presenters: Joycelyn Woods & Jo Sotheran, NAMA

1 P.M. to 5 P.M. Session: The Vision Of The Future

The Graying of Methadone Maintnenace Treatment
Presenter: C. Todd Rosendale, CSAT/OPAT

Making Accreditation Work For You: a How-To for Patients and Programs
Presenter: Joycelyn Woods, NAMA

Warm and Fuzzy With the Community
Presenter: Fred Christie, AFIRM

How to Start an Advocacy Group
Presenter: James DePasquale, NAMA

Methadone Works; Medical Efficacy From the Patient’s Perspective
Presenter: Sean P. Murphy

Pictures

Howard is Ready

Howard is Ready!

Howard Lotsof, Acting Membership Director and member of NAMA’s Board prepares for the preconference day.

Jo Presents

Jo Makes a Point

Jo Presents.

Jo Sotheran, Treasurer and member of NAMA’s board talks about the importance of planning at a conference.

Jo Makes a Point and shows the advocates how to use a conference program to set goals for a conference.

Donna Schoen helps James DePasquale.

Donna Schoen (LIJ Patient Committee) helps James DePasquale, former Membership Director talk about starting an advocacy group.

Operations and Oversight!

Operations and Oversight

Jo Sotheran talks methadone politics and patient rights with Joycelyn S. Woods, NAMA’s President

Sponsored by the Center for Substance Abuse Treatment


Return to AMTA 2001 Index

Similar Posts

  • Focus On

    Admin 02/26/2023

    Issues To Focus On Massachusetts Restores Methadone Funding Highlights from a compromise budget plan unveiled by House and Senate leaders on Thursday The $22.3 billion plan would: Restore Medicaid funding for 36,000 people under MassHealth Basic; Preserve a popular prescription drug coverage program for the elderly; Repeal the voter-approved Clean Elections law; Tighten the Quinn…

  • Grievence Report Form Webpage

    Admin 04/04/2021

    Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Treatment (CSAT) Telephone (240) 276-2717 1Choke Cherry Road, Room 2-1065 Facsimile (240) 276-1630 Rockville, Maryland 20857 E-mail: [email protected] Division of Pharmacologic Therapies DPT C. Todd Rosendale, MA Public Health Advisor ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ FACSIMILE AInformation Memorandum@   This facsimile is intended only for the addressee…

  • Contact NAMA

    Admin 09/05/2021

    National Alliance for Medication Assisted Recovery (NAMA Recovery) 435 Second Avenue New York, NY 10010 Phone/Fax: (212) 595-NAMA/6262 For More Information Contact:    The President’s Office Directory of Affiliates and Chapters

  • National Methadone Conference Indexes

    Admin 07/26/2021

    2005 National Alliance of Methadone Advocates. Letter to HBO. Re: Methadonia. October 4, 2005. White, D. MAP. Letter to Linda Martz . News-Journal (Mansfield, OH), January 6, 2005. Kitts, C. Virginia NAMA. Letter to the Editor . Roanoke Times, January 3, 2005. 2004 Mandel, G. Maryland NAMA. Letter to Sheriff Chris Curry. November 9, 2004. Woods, J. National Alliance…

  • |

    Basic Information for Patients About Buprenorphine

    Admin 11/29/2021

    Basic Information About Buprenorphine Federal Law For the first time in nearly a century physicians may now treat opiate addiction. On October 17, 2000 Title XXXV of the Children’s Health Act of 2000 was enacted that permits the prescribing of certain medications to treat opiate addiction. Physicians may now prescribe Schedule III, IV, and V…

  • Patient “vs” Client

    Admin 12/04/2022

    Policy Statement Number 4 May 1994 Over the years methadone providers and patients have begun using client in place of patient. While this maybe well intended NAMA is concerned that the results could become damaging to methadone treatment, and most especially to patients. The use of client is deprogating to methadone patients, inferring that their…